ArticleInternational journal of nanomedicine2017

A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects.

Shao-Jun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.